-
公开(公告)号:US09487566B2
公开(公告)日:2016-11-08
申请号:US14129677
申请日:2012-06-28
CPC分类号: C07K14/4703 , C07K1/165 , C07K1/18 , C07K14/8128
摘要: The present invention relates to protein purification. More particularly, a method for directly recovering an objective protein from a protein composition and purifying a protein with a desired quality in a rapid and efficient manner is provided. Further, a rapid purification method capable of efficiently removing impurities included in the protein composition is provided. Therefore, compared to the conventional purification methods, quality and yield of the protein can be remarkably improved.
摘要翻译: 本发明涉及蛋白质纯化。 更具体地,提供了一种从蛋白质组合物中直接回收目标蛋白质并以快速且有效的方式纯化具有所需质量的蛋白质的方法。 此外,提供能够有效地除去蛋白质组合物中所含的杂质的快速纯化方法。 因此,与常规的纯化方法相比,可以显着提高蛋白质的质量和产率。
-
公开(公告)号:US06872803B1
公开(公告)日:2005-03-29
申请号:US09349707
申请日:1999-07-08
申请人: Kenji Shibata , Toshiyuki Suzawa , Motoo Yamasaki , Koji Yamada , Tatsuhiro Ogawa , Takeo Tanaka , Shiro Soga
发明人: Kenji Shibata , Toshiyuki Suzawa , Motoo Yamasaki , Koji Yamada , Tatsuhiro Ogawa , Takeo Tanaka , Shiro Soga
IPC分类号: C07K14/58 , C07K14/745 , A61K38/10
CPC分类号: C07K14/745 , C07K14/58
摘要: The present invention provides peptides represented by the following formula (A): wherein Q represents a physiologically active peptide moiety; X each represents the same or different α-amino acid residue; M represents Gly or Cys; m represents an integer of from 5 to 8; and n represents an integer of from 0 to 3, or their pharmaceutically acceptable salts thereof. The peptides of the present invention have higher stability and/or higher activity than physiologically active linear peptides to which no cyclic peptide is bonded.
摘要翻译: 本发明提供由下式(A)表示的肽:其中Q表示生理活性肽部分; X各自表示相同或不同的α-氨基酸残基; M表示Gly或Cys; m表示5〜8的整数, 和n表示0〜3的整数,或其药学上可接受的盐。本发明的肽与没有结合肽的生理活性线性肽相比,具有更高的稳定性和/或更高的活性。
-
公开(公告)号:US20050063936A1
公开(公告)日:2005-03-24
申请号:US10470680
申请日:2002-01-30
申请人: Motoo Yamasaki , Toshiyuki Suzawa , Tatsuya Murakami , Noriko Sakurai , Kinya Yamashita , Mayumi Makai , Takashi Kuwabara
发明人: Motoo Yamasaki , Toshiyuki Suzawa , Tatsuya Murakami , Noriko Sakurai , Kinya Yamashita , Mayumi Makai , Takashi Kuwabara
IPC分类号: A61K38/00 , A61K47/48 , C08G65/329 , C08G65/331 , A61K38/19 , A61K31/785 , C07K14/52
CPC分类号: C08G65/3311 , A61K38/00 , A61K47/60 , A61K47/62 , A61K47/641 , A61K47/642 , C08G65/329 , C08L2203/02
摘要: The present invention provides a branched polyalkylene glycol wherein three or more single-chain polyalkylene glycols and a group having reactivity with an amino acid side chain, the N-terminal amino group or the C-terminal carboxyl group in a polypeptide or a group convertible into the group having reactivity are bound; and a physiologically active polypeptide modified with the branched polyalkylene glycol.
摘要翻译: 本发明提供一种支链聚亚烷基二醇,其中三个或更多个单链聚亚烷基二醇和与多肽或可转化为多肽的基团的氨基酸侧链,N-末端氨基或C-末端羧基具有反应性的基团 具有反应性的基团被结合; 和用支链聚亚烷基二醇改性的生理活性多肽。
-
公开(公告)号:US06642355B2
公开(公告)日:2003-11-04
申请号:US09750754
申请日:2001-01-02
申请人: Takeo Tanaka , Yoshikazu Morishita , Mika Makino , Shigeru Chiba , Isao Kawamoto , Eiji Tsukuda , Mayumi Yoshida , Chieko Bando , Kazuo Yamaguchi , Yuzuru Matsuda , Shigeto Kitamura , Toshihide Ikemura , Tatsuhiro Ogawa , Keiichi Yano , Toshiyuki Suzawa , Kenji Shibata , Motoo Yamasaki
发明人: Takeo Tanaka , Yoshikazu Morishita , Mika Makino , Shigeru Chiba , Isao Kawamoto , Eiji Tsukuda , Mayumi Yoshida , Chieko Bando , Kazuo Yamaguchi , Yuzuru Matsuda , Shigeto Kitamura , Toshihide Ikemura , Tatsuhiro Ogawa , Keiichi Yano , Toshiyuki Suzawa , Kenji Shibata , Motoo Yamasaki
IPC分类号: C07K700
CPC分类号: C07K7/06 , A61K38/00 , C07K5/1021 , C07K5/1024 , C07K7/08 , C07K14/36 , C07K14/57536 , C12R1/465
摘要: The invention relates to an endothelin antagonistic peptide of the formula (I): X-A-Trp-B-Gly-Thr-E-G-Y (I) SEQ ID NO: 2 wherein represents Asn or Asp; B represents His or Lys; E represents Ala or Ser; G represents Ala or Pro; X represents X1-Gly or and Y represents hydroxy, lower alkoxy, amino, wherein X1, X3, Y1, Y2 and Z are further defined, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明涉及式(I)的内皮素拮抗肽:其中代表Asn或Asp; B代表His或Lys; E表示Ala或Ser; G表示Ala或Pro; X表示X 1 -Gly或Y表示羟基,低级烷氧基,氨基,其中X 1,X 3,Y 1,Y 2和Z进一步定义,或 其药学上可接受的盐。
-
公开(公告)号:US06638509B1
公开(公告)日:2003-10-28
申请号:US09500243
申请日:2000-02-08
申请人: Toshiyuki Suzawa , Motoo Yamasaki , Satoru Nagamura , Hiromitsu Saito , So Ohta , Nobuo Hanai
发明人: Toshiyuki Suzawa , Motoo Yamasaki , Satoru Nagamura , Hiromitsu Saito , So Ohta , Nobuo Hanai
IPC分类号: A61K3940
CPC分类号: A61K39/44 , A61K47/6809 , A61K47/6817 , A61K47/6889 , C07K17/06
摘要: The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
摘要翻译: 本发明涉及一种毒素结合物,其中衍生自对靶细胞具有亲和力的化合物的残基通过包含聚亚烷基二醇和二肽的间隔物与毒素结合。
-
公开(公告)号:US06583267B2
公开(公告)日:2003-06-24
申请号:US09230733
申请日:1999-02-03
申请人: Motoo Yamasaki , Toshiyuki Suzawa , Ken Kobayashi , Noboru Konishi , Shiro Akinaga , Kumiko Maruyama
发明人: Motoo Yamasaki , Toshiyuki Suzawa , Ken Kobayashi , Noboru Konishi , Shiro Akinaga , Kumiko Maruyama
IPC分类号: A61K3816
CPC分类号: C07K1/1077 , A61K38/00 , C07K14/535
摘要: The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypeptide; use of the modified polypeptide; a pharmaceutical preparation comprising the modified polypeptide; and a composition for treatment comprising the modified polypeptide.
-
公开(公告)号:US5631222A
公开(公告)日:1997-05-20
申请号:US382013
申请日:1995-02-10
申请人: Kenji Shibata , Toshiyuki Suzawa , Motoo Yamasaki , Takeo Tanaka , Eiji Tsukuda , Koji Yamada , Tetsuji Ohno
发明人: Kenji Shibata , Toshiyuki Suzawa , Motoo Yamasaki , Takeo Tanaka , Eiji Tsukuda , Koji Yamada , Tetsuji Ohno
IPC分类号: A61K38/00 , C07K7/06 , C07K14/575 , C07K5/12 , C07K7/08
CPC分类号: C07K7/06 , C07K14/57536 , A61K38/00
摘要: Disclosed is a peptide compound represented by the following formula (I):R.sup.1 -R.sup.2 -R.sup.3 -R.sup.4 -R.sup.5 -R.sup.6 -R.sup.7 -R.sup.8 -R.sup.9 -R.sup.10 -R.sup.11 -R.sup.12 -Phe-R.sup.14 -R.sup.15 -R.sup.16 -R.sup.17 -R.sup.18 -Ile-R.sup.20 -Z SEQ. ID NO. 64, (I)wherein R.sup.1-12, R.sup.14-18, and R.sup.20 are as defined in the specification.
摘要翻译: PCT No.PCT / JP94 / 01011 Sec。 371日期1995年2月10日 102(e)1995年2月10日PCT PCT 1994年6月23日PCT公布。 第WO95 / 00546号公报 日期:1995年5月1日公开了由下式(I)表示的肽化合物:R1-R2-R3-R4-R5-R6-R7-R8-R9-R10-R11-R12-Phe-R14-R15-R16- R17-R18-Ile-R20-Z SEQ。 证件号码。 64,(I)其中R1-12,R14-18和R20如说明书中所定义。
-
公开(公告)号:US20100172967A1
公开(公告)日:2010-07-08
申请号:US12708714
申请日:2010-02-19
申请人: Hisao Nemoto , Masahiro Yamauchi , Hiroko Kusano , Yasuki Kato , Motoo Yamasaki , Toshiyuki Suzawa
发明人: Hisao Nemoto , Masahiro Yamauchi , Hiroko Kusano , Yasuki Kato , Motoo Yamasaki , Toshiyuki Suzawa
CPC分类号: C07D207/452 , A61K47/00 , A61K47/54 , A61K47/6911 , B82Y5/00 , C07C323/60 , C07F9/10 , C07K5/0202
摘要: Objects of the present invention are to provide a compound which is useful as a surface modifier for producing a drug carrier or the like, or a salt thereof; a fine particle comprising the same; and the like. The present invention provides a compound in which a substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, is modified with a glycerol derivative represented by the following formula (1): wherein R represents a residue comprising a reactive group for the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance or for a spacer capable of binding the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, to R—X, or a group capable of being transformed into the reactive group; n represents an integer of 3 or more; and X represents a residue capable of having the following structure by n in number: directly or via the spacer, or a salt thereof; a fine particle comprising the same; and the like.
摘要翻译: 本发明的目的是提供一种可用作生产药物载体等的表面改性剂或其盐的化合物; 包含该颗粒的细颗粒; 等等。 本发明提供一种化合物,其中选自由两亲物质和疏水性物质组成的组中的被改性物质用下式(1)表示的甘油衍生物进行改性:其中R表示残基 包括选自两亲物质和疏水性物质的待修饰物质的反应性基团或能够与被修饰物质结合的间隔基,其选自两亲物质 和疏水性物质,R-X或能够转化为反应性基团的基团; n表示3以上的整数, X表示可以直接或经由间隔基或其盐具有n数的以下结构的残基: 包含该颗粒的细颗粒; 等等。
-
公开(公告)号:US07696359B2
公开(公告)日:2010-04-13
申请号:US10570623
申请日:2004-09-03
申请人: Hisao Nemoto , Masahiro Yamauchi , Hiroko Kusano , Yasuki Kato , Motoo Yamasaki , Toshiyuki Suzawa
发明人: Hisao Nemoto , Masahiro Yamauchi , Hiroko Kusano , Yasuki Kato , Motoo Yamasaki , Toshiyuki Suzawa
IPC分类号: C07D207/46 , C07F9/09
CPC分类号: C07D207/452 , A61K47/00 , A61K47/54 , A61K47/6911 , B82Y5/00 , C07C323/60 , C07F9/10 , C07K5/0202
摘要: Objects of the present invention are to provide a compound which is useful as a surface modifier for producing a drug carrier or the like, or a salt thereof; a fine particle comprising the same; and the like. The present invention provides a compound in which a substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, is modified with a glycerol derivative represented by the following formula (1): wherein R represents a residue comprising a reactive group for the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance or for a spacer capable of binding the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, to R-X, or a group capable of being transformed into the reactive group; n represents an integer of 3 or more; and X represents a residue capable of having the following structure by n in number: directly or via the spacer, or a salt thereof; a fine particle comprising the same; and the like.
摘要翻译: 本发明的目的是提供一种可用作生产药物载体等的表面改性剂或其盐的化合物; 包含该颗粒的细颗粒; 等等。 本发明提供一种化合物,其中选自由两亲物质和疏水性物质组成的组中的被改性物质用下式(1)表示的甘油衍生物进行改性:其中R表示残基 包括选自两亲物质和疏水性物质的待修饰物质的反应性基团或能够与被修饰物质结合的间隔基,其选自两亲物质 和疏水性物质,至RX或能够转化为反应性基团的基团; n表示3以上的整数, X表示可以直接或经由间隔基或其盐具有n数的以下结构的残基: 包含该颗粒的细颗粒; 等等。
-
公开(公告)号:US07569706B2
公开(公告)日:2009-08-04
申请号:US10529216
申请日:2003-09-02
IPC分类号: C07D207/08 , C07C231/02 , C07C29/03
CPC分类号: C07D207/404 , A61K47/54 , A61K47/6949 , B82Y5/00 , C07C233/78 , C07C237/22 , C07C323/60
摘要: (wherein R represents a residue comprising a reactive group or a group capable of being transformed into the reactive group; n represents an integer of 3 or more; and X represents a residue capable of having the following structure by n in number: R1s each represent a hydrogen atom or a group capable of being transformed into a hydrogen atom, and 6 or more of R1s may be the same or different) The compound represented by the above formula (1), which is capable of modifying a physiologically active polypeptide or a derivative thereof, or a low molecular compound while maintaining the physiological activity, or which is useful for improving the stability or water-solubility of the low molecular compound, are provided.
摘要翻译: (其中R表示含有能够转化为反应性基团的反应性基团或基团的残基; n表示3以上的整数,X表示可以具有如下结构的残基数:n表示 氢原子或能够转化成氢原子的基团,6个以上的R 1可以相同也可以不同,上述式(1)表示的化合物能够改变生理活性多肽或 衍生物或低分子化合物,同时保持生理活性,或可用于提高低分子化合物的稳定性或水溶性。
-
-
-
-
-
-
-
-
-